EM equities outperform as growth outlook improves EM equities outperform as growth outlook improves EM equities outperform as growth outlook improves

EM equities outperform as growth outlook improves

Equities 4 minutes to read
Peter Garnry

Head of Equity Strategy

Summary:  Equity markets continue to rise as further evidence from OECD suggest the economy is rebounding led by Asia. Our current allocation view is to remain overweight Europe and EM equities, and underweight US equities. The earnings season starts this week and while EPS y/y will be another negative print investors will focus more on the outlook. We expect the technology sector to be the best performing sector in this earnings season.

We started the year with several predictions in 2020 and our current allocation view. One of our key views is to be overweight emerging market and European equities, and underweight US equities while staying selectively overweight the US technology sector. This allocation is based on two assumptions, 1) that equity markets behave according to history when the economy is a recovery phase and, 2) Europe will benefit more than the US from the rebound in Asia. So far, we have been right on EM equities outperforming US equities while European equities are a little behind. The rebound trade got more support today with South Korea exports y/y improving more than expected although the nominal figures are flat q/q.

Adding to the positive equities vs bonds trade is the OECD leading indicators released today revising some prior months data. The indicators are now suggesting that the growth momentum in the global economy bottomed in August last year and has been rebound ever since. This observation fits with this machine learning recession probability model that we are tracking. However, despite the recession probability has declined it still remains at 32% for the US economy within the next 12 months. But it looks increasingly like governments and central banks avoided a recession again. The cost short term looks small but the fallout will be a more leveraged system which imply a harder reset when the economy one day runs out of steam.

Equity valuations on the MSCI World Index rose to one standard deviation in December eclipsing the high from January 2018 and are now on par with the levels in 2007. US equity valuations are now at 1.2 standard deviations and now moving in on the levels observed during the dot-com bubble. What we are likely observing is the effect of investor expectations anchoring at very low interest rate levels in the long term. In this scenario, even a low growth economy, stable cash flows from stable companies will be bid up massively in price mimicking a bond with a credit and recession risk spread implied in the free cash flow yield.

While we do acknowledge various dangers to the equity market our view is that momentum remains strong. Implied equity volatility suggest more positive equity returns in the near term and investors are adding the least protection in option markets to protect the downside. This is positive short term but it also comes with the risk of a much larger drawdown when the equity market naturally resets temporarily.

The earnings season starts week and will be the fourth quarterly EPS decline y/y for US companies but the market is looking beyond that. As long as company outlooks start to improve and macro data on balance improve then equities will hold the line. We expect the technology sector to be strong during the earnings season together with financials and health care stocks.


The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-hk/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK Limited (“Saxo”) is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo holds a Type 1 Regulated Activity (Dealing in Securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged Foreign Exchange Trading); Type 4 Regulated Activity (Advising on Securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products may result in your losses exceeding your initial deposits. Saxo does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo does not take into account an individual’s needs, objectives or financial situation. Please click here to view the relevant risk disclosure statements.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-hk/about-us/awards.

The information or the products and services referred to on this site may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and services offered on this website are not directed at, or intended for distribution to or use by, any person or entity residing in the United States and Japan. Please click here to view our full disclaimer.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc. Android is a trademark of Google Inc.